Free Trial

Spire Healthcare Group (LON:SPI) Trading 13.4% Higher - Here's What Happened

Spire Healthcare Group logo with Medical background

Key Points

  • Spire Healthcare Group's stock price surged by 13.4% to GBX 245.50 ($3.33) during mid-day trading, marking a significant increase in trading volume of 2,397% compared to its average.
  • Analysts rate the stock positively, with a consensus target price of GBX 294.33, and Berenberg Bank maintaining a "buy" rating with a target of GBX 280.
  • The company's recent earnings report revealed an EPS of GBX 4.10 and a projected EPS of 15.66 for the current fiscal year, indicating a modest return on equity of 3.82%.
  • MarketBeat previews the top five stocks to own by October 1st.

Shares of Spire Healthcare Group plc (LON:SPI - Get Free Report) shot up 13.4% on Friday . The stock traded as high as GBX 256.50 ($3.46) and last traded at GBX 245.50 ($3.31). 40,970,105 shares traded hands during mid-day trading, an increase of 2,397% from the average session volume of 1,640,628 shares. The stock had previously closed at GBX 216.50 ($2.92).

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on SPI. Berenberg Bank restated a "buy" rating and set a GBX 280 price target on shares of Spire Healthcare Group in a research report on Thursday, July 31st. JPMorgan Chase & Co. reduced their target price on shares of Spire Healthcare Group from GBX 309 to GBX 303 and set an "overweight" rating for the company in a research report on Tuesday, August 5th. Three research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company currently has a consensus rating of "Buy" and an average price target of GBX 294.33.

View Our Latest Research Report on SPI

Spire Healthcare Group Stock Performance

The stock has a market capitalization of £993.86 million, a P/E ratio of 5,369.57, a PEG ratio of 1.06 and a beta of 0.96. The company has a quick ratio of 0.74, a current ratio of 0.70 and a debt-to-equity ratio of 62.25. The company has a 50-day moving average price of GBX 218.75 and a two-hundred day moving average price of GBX 203.41.

Spire Healthcare Group (LON:SPI - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The company reported GBX 4.10 earnings per share for the quarter. Spire Healthcare Group had a net margin of 1.96% and a return on equity of 3.82%. Equities analysts expect that Spire Healthcare Group plc will post 15.6634747 earnings per share for the current year.

Spire Healthcare Group Company Profile

(Get Free Report)

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.

Featured Stories

Should You Invest $1,000 in Spire Healthcare Group Right Now?

Before you consider Spire Healthcare Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spire Healthcare Group wasn't on the list.

While Spire Healthcare Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.